{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT03168776", "pid": "35", "mcid": "963", "text": "the patient is an acceptable candidate for percutaneous coronary intervention (pci) with drug-eluting stents and for emergent coronary bypass graft (cabg) surgery.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT03153137", "pid": "35", "mcid": "1593", "text": "fontan-palliated subjects with either intra-atrial lateral tunnel total cavopulmonary connection (lt-tcpc) or extra cardiac tunnel tcpc (ec-tcpc) surgery > 1 year before screening", "entities": [{"id": 551, "label": "TVariable", "start_offset": 0, "end_offset": 96}, {"id": 552, "label": "TCreGt", "start_offset": 154, "end_offset": 155}, {"id": 553, "label": "TValue", "start_offset": 156, "end_offset": 157}, {"id": 554, "label": "TUnit", "start_offset": 158, "end_offset": 162}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT03130777", "pid": "35", "mcid": "2634", "text": "need for concomitant atrial septal defect or ventricular septal defect closure or other concomitant interventional procedures other than pulmonary artery or branch pulmonary artery stenting or angioplasty", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT03115918", "pid": "35", "mcid": "3235", "text": "patients with pancreatic fluid collection > 3cm in size located along the course of the main pd on cross-sectional imaging prior to the initial ercp", "entities": [{"id": 555, "label": "TVariable", "start_offset": 0, "end_offset": 41}, {"id": 556, "label": "TCreGt", "start_offset": 42, "end_offset": 43}, {"id": 557, "label": "TValue", "start_offset": 44, "end_offset": 45}, {"id": 558, "label": "TUnit", "start_offset": 45, "end_offset": 47}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT03107897", "pid": "35", "mcid": "3835", "text": "subject has significant severe un-revascularized epicardial coronary disease.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT03068442", "pid": "35", "mcid": "5772", "text": "patients with carotid occlusion will be excluded, due to one carotid contributing to both right and left brain blood supply.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02944825", "pid": "35", "mcid": "11245", "text": "patients with indwelling ureteral stents placed within the 2 weeks prior to the procedure visit for removal", "entities": [{"id": 559, "label": "TVariable", "start_offset": 0, "end_offset": 47}, {"id": 560, "label": "TCreLt", "start_offset": 48, "end_offset": 54}, {"id": 561, "label": "TValue", "start_offset": 59, "end_offset": 60}, {"id": 562, "label": "TUnit", "start_offset": 61, "end_offset": 66}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02930018", "pid": "35", "mcid": "11695", "text": "intent to use any endovascular device other than a stent retriever or clot aspiration device or intra-arterial medications as the initial thrombectomy approach.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02924363", "pid": "35", "mcid": "11984", "text": "the patient is scheduled to undergo percutaneous coronary intervention with mitraclip procedure.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02806570", "pid": "35", "mcid": "15636", "text": "anatomical pathology/constraints preventing appropriate access/implant of the accucinch ventricular restoration system (e.g., femoral arteries will not support a 20f system)", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02765633", "pid": "35", "mcid": "16645", "text": "postoperative neonatal cardiac participants with placement of systemic-to-pulmonary artery palliative shunts, right ventricle to pulmonary artery palliative shunts or ductus arteriosus stents who are at risk of thrombotic events after repair for structural congenital heart disease.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02758847", "pid": "35", "mcid": "16950", "text": "patient population: all patients with cli (critical limb ischemia) and tissue loss scheduled for endovascular intervention for femoral popliteal occlusive or multilevel disease.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02758847", "pid": "35", "mcid": "16956", "text": "iliac inflow or tibial outflow interventions can be done at the discretion of the investigator with standard balloon percutaneous transluminal angioplasty (pta)", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02744677", "pid": "35", "mcid": "17251", "text": "angiographic evidence of coronary artery compression that would result from transcatheter pulmonic valve implantation (tpvi)", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02594501", "pid": "35", "mcid": "21076", "text": "bifurcation interventions with a planned 2-stent strategy", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02578732", "pid": "35", "mcid": "22133", "text": "patients with unstable biliary stents or with plastic stents. information on type of stent is required at registration.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02564796", "pid": "35", "mcid": "22913", "text": "cyanotic heart disease who have had a surgical shunt or a catheterization intervention that is equivalent to a shunt (patent ductus arteriosus stent, right ventricular outflow tract stent).", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02516332", "pid": "35", "mcid": "25592", "text": "men and women with documented chd (i.e., a prior mi, coronary revascularization procedure or >70% stenosis in at least one coronary artery)", "entities": [{"id": 563, "label": "TVariable", "start_offset": 53, "end_offset": 89}, {"id": 564, "label": "TCreGt", "start_offset": 43, "end_offset": 48}, {"id": 565, "label": "TValue", "start_offset": 94, "end_offset": 96}, {"id": 566, "label": "TUnit", "start_offset": 96, "end_offset": 97}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02513797", "pid": "35", "mcid": "25796", "text": "previously attempted occlusion of the left atrial appendage (by any surgical or percutaneous method);", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02479620", "pid": "35", "mcid": "27738", "text": "<p>angiographic/procedural criteria:</p><ul><li>hemodynamically significant inflow lesion (50% ds) or occlusion in the ipsilateral iliac, sfa or popliteal arteries in which there is failure to successfully treat and obtain a &lt;30% residual stenosis</li><li>target lesion length is &gt;25 cm as measured from proximal normal vessel to distal normal vessel</li><li>total length of lesions treated during the case (including target lesion, inflow lesions and other non-target lesions) &gt;25 cm</li><li>lesions revascularized during the index case but untreated by bullfrog</li><li>use of alternative therapy, e.g", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02464969", "pid": "35", "mcid": "28727", "text": "thrombectomy, thrombolytic therapy or insertion of a caval filter to treat the index vte.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02389023", "pid": "35", "mcid": "32290", "text": "femoral endarterectomy with or without patch angioplasty involving the common femoral artery and/or profunda and/or proximal superficial artery. the index groin may have undergone prior procedures (may be inflow or outflow for existing grafts) but the patient must have fully healed from the prior operation. may include patients with concomitant proximal and/or distal peripheral vascular intervention. the patch may be autogenous venous or arterial or prosthetic material such as bovine pericardium, dacron or polytetrafluoroethylene (ptfe). bilateral femoral endarterectomies are eligible for enrollment. the right and left groin incision would be randomized to the same dressing which is consistent with routine clinical practice.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02365467", "pid": "35", "mcid": "33068", "text": "subject has had previous endovascular repair of the ascending and/or descending thoracic aorta <30 days of implantation of investigational device or previous repair was a non-medtronic device", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02365467", "pid": "35", "mcid": "33082", "text": "subject has had previous surgical or endovascular treatment of an infra-renal aortic aneurysm <30 days of implantation of investigational device.", "entities": [{"id": 567, "label": "TVariable", "start_offset": 0, "end_offset": 93}, {"id": 568, "label": "TCreLt", "start_offset": 94, "end_offset": 95}, {"id": 569, "label": "TValue", "start_offset": 95, "end_offset": 97}, {"id": 570, "label": "TUnit", "start_offset": 98, "end_offset": 102}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02316886", "pid": "35", "mcid": "35238", "text": "patients for whom the preferred treatment is cabg(coronary artery bypass grafting)", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02316886", "pid": "35", "mcid": "35244", "text": "patients with bifurcation lesions requiring 2 stenting technique", "entities": [{"id": 571, "label": "TVariable", "start_offset": 0, "end_offset": 43}, {"id": 572, "label": "", "start_offset": -1, "end_offset": -1}, {"id": 573, "label": "TValue", "start_offset": 44, "end_offset": 45}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02276456", "pid": "35", "mcid": "36425", "text": "patients treated with coronary artery bypass grafting will be excluded for the purposes of this trial to avoid conflicts with usual post-operative management.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02266719", "pid": "35", "mcid": "36879", "text": "1native vessel or surgical graft 2diameter: 5-20mm 3length of sealing zone 10mm 4acceptable tortuosity 4", "entities": [{"id": 574, "label": "TVariable", "start_offset": 1, "end_offset": 32}, {"id": 575, "label": "", "start_offset": -1, "end_offset": -1}, {"id": 576, "label": "TValue", "start_offset": 33, "end_offset": 34}, {"id": 577, "label": "TVariable", "start_offset": 34, "end_offset": 42}, {"id": 578, "label": "TCreVtoV", "start_offset": 44, "end_offset": 48}, {"id": 579, "label": "TValue", "start_offset": 44, "end_offset": 45}, {"id": 580, "label": "TUnit", "start_offset": 48, "end_offset": 50}, {"id": 581, "label": "TValue", "start_offset": 46, "end_offset": 48}, {"id": 582, "label": "TValue", "start_offset": 51, "end_offset": 52}, {"id": 583, "label": "TVariable", "start_offset": 52, "end_offset": 74}, {"id": 584, "label": "TValue", "start_offset": 75, "end_offset": 77}, {"id": 585, "label": "TValue", "start_offset": 80, "end_offset": 81}, {"id": 586, "label": "TVariable", "start_offset": 81, "end_offset": 102}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02266719", "pid": "35", "mcid": "36881", "text": "6iliac anatomy must allow for the delivery of the arch branch device which is loaded within a 20f-24f sheath", "entities": [{"id": 587, "label": "TVariable", "start_offset": 1, "end_offset": 84}, {"id": 588, "label": "", "start_offset": -1, "end_offset": -1}, {"id": 589, "label": "TValue", "start_offset": 94, "end_offset": 96}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02266719", "pid": "35", "mcid": "36892", "text": "a true lumen size large enough to deploy the device and still gain access into the target branches 5", "entities": [{"id": 590, "label": "TVariable", "start_offset": 2, "end_offset": 98}, {"id": 591, "label": "", "start_offset": -1, "end_offset": -1}, {"id": 592, "label": "TValue", "start_offset": 99, "end_offset": 100}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02259504", "pid": "35", "mcid": "37130", "text": "<p>candidates for this study must meet all of the following criteria to be enrolled in the study:</p><ol><li>subject age 18 and 80 with a diagnosis of ruptured or unruptured saccular intracranial aneurysm judged suitable for selective endovascular treatment by coil occlusion</li><li>aneurysm size [largest measurement from the cross sectional images to determine overall aneurysm size, not just the lumen and including any thrombosed portions] 4.9 mm</li><li>if ruptured aneurysm: hunt and hess 0-3</li><li>if unruptured aneurysm: subject grade modified rankin scale mrs 0 - 2 the investigator believes the aneurysm is appropriate for the designated phase coiling paradigm(phase 1: frame, fill and finish with microvention hypersoft 3d and/or hypersoft helical coils)the operator at his discretion may frame with any bare metal framing coil but the remainder of the coils must be hypersoft 3d or hypersoft helical coilsphase 2: frame with microvention hydroframe or hydrosoft 3d coils and fill/finish with sufficient hydrogel coils to ensure 50% hydrogel by lengthhowever, at the discretion of the treating physician, a bare platinum coil may be used to fill or finish, as long as a minimum of 50% (in total coil length) of hydrogel coils are used.</li><li>signed informed consent.</li></ol>", "entities": [{"id": 593, "label": "TVariable", "start_offset": 117, "end_offset": 120}, {"id": 594, "label": "", "start_offset": -1, "end_offset": -1}, {"id": 595, "label": "TValue", "start_offset": 121, "end_offset": 123}, {"id": 596, "label": "TValue", "start_offset": 128, "end_offset": 130}, {"id": 597, "label": "TCreLt", "start_offset": 0, "end_offset": 1}, {"id": 598, "label": "TValue", "start_offset": 445, "end_offset": 448}, {"id": 599, "label": "TUnit", "start_offset": 449, "end_offset": 451}, {"id": 600, "label": "TCreVtoV", "start_offset": 496, "end_offset": 499}, {"id": 601, "label": "TValue", "start_offset": 129, "end_offset": 130}, {"id": 602, "label": "TValue", "start_offset": 498, "end_offset": 499}, {"id": 603, "label": "TValue", "start_offset": 576, "end_offset": 577}, {"id": 604, "label": "TVariable", "start_offset": 690, "end_offset": 733}, {"id": 605, "label": "TUnit", "start_offset": 6, "end_offset": 7}, {"id": 606, "label": "TVariable", "start_offset": 772, "end_offset": 890}, {"id": 607, "label": "TVariable", "start_offset": 929, "end_offset": 976}, {"id": 608, "label": "TValue", "start_offset": 1043, "end_offset": 1045}, {"id": 609, "label": "TUnit", "start_offset": 1045, "end_offset": 1046}, {"id": 610, "label": "TVariable", "start_offset": 1121, "end_offset": 1169}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02201589", "pid": "35", "mcid": "38733", "text": "patients who have a condition that threatens to infect the stent graft/aortic valve prosthesis;", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02121158", "pid": "35", "mcid": "41465", "text": "coronary artery bypass graft (cabg) or percutaneous transluminal coronary angioplasty (ptca) within the past 3 months", "entities": [{"id": 611, "label": "TVariable", "start_offset": 39, "end_offset": 85}, {"id": 612, "label": "TCreGte", "start_offset": 93, "end_offset": 99}, {"id": 613, "label": "TNegativeValue", "start_offset": 104, "end_offset": 110}, {"id": 614, "label": "TValue", "start_offset": 109, "end_offset": 110}, {"id": 615, "label": "TUnit", "start_offset": -1, "end_offset": 10}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02100722", "pid": "35", "mcid": "42118", "text": "15", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02098876", "pid": "35", "mcid": "42160", "text": "lesion treatable by a single resolute integrity or onyx abbott xience xpedition or sierra coronary drug-eluting stent.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02098876", "pid": "35", "mcid": "42169", "text": "lesions at bifurcations and those that occlude side branches >2.5mm", "entities": [{"id": 616, "label": "TVariable", "start_offset": 0, "end_offset": 60}, {"id": 617, "label": "TCreGt", "start_offset": 61, "end_offset": 62}, {"id": 618, "label": "TValue", "start_offset": 62, "end_offset": 65}, {"id": 619, "label": "TUnit", "start_offset": 65, "end_offset": 67}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02089607", "pid": "35", "mcid": "42421", "text": "exclusion criteria:</p><ul><li>less than 18 years of age</li><li>unwilling to comply with the follow-up schedule</li><li>inability or refusal to give informed consent by the patient or a legally authorized representative</li><li>pregnant or breastfeeding</li><li>life expectancy &lt2 years</li><li>prior open surgical or interventional procedure within 30 days of the anticipated date of the fenestrated-branched procedure, with the exception of planned staged procedures to provide access for repair (e.g30 days)examples include remote (&gt;30 days) participation in a thoracic, abdominal or iliac branch device trial or participation in a percutaneous aortic valve trial", "entities": [{"id": 620, "label": "TVariable", "start_offset": 53, "end_offset": 56}, {"id": 621, "label": "TCreLt", "start_offset": 19, "end_offset": 20}, {"id": 622, "label": "TValue", "start_offset": 41, "end_offset": 43}, {"id": 623, "label": "TUnit", "start_offset": 44, "end_offset": 49}, {"id": 624, "label": "TVariable", "start_offset": 513, "end_offset": 536}, {"id": 625, "label": "", "start_offset": -1, "end_offset": -1}, {"id": 626, "label": "TValue", "start_offset": 353, "end_offset": 355}, {"id": 627, "label": "TUnit", "start_offset": 356, "end_offset": 360}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02089607", "pid": "35", "mcid": "42424", "text": "diameter: 20-42mmproximal neck length 20mmascending aortic length 50mmdiameter: 20-42mmdistal neck length 20mm</li><li>supra-aortic trunk (brachiocephalic) vessels: aa design with a single subclavian retrograde branch and double scallop to the left carotid artery may be used to extent the landing zone to zone 1thus the inclusion criteria are defined for each artery, yet any combination of arteries may be used for a repair: innominate artery (native vessel or surgical graft, diameter: 8-22mm, length of sealing zone 10mm, acceptable tortuosity)left (or right) common carotid artery (native vessel or surgical graft, diameter 6-16mm, length of sealing zone 10mm, acceptable tortuosity)left (or right) common carotid artery (native vessel or surgical graft, diameter: 5-20mm, length of sealing zone 10mm, acceptable tortuosity).</li><li>in the setting of an aortic dissection the following criteria must exist: athe repair may be coupled with a thoracoabdominal branched device, infrarenal device, and/or internal iliac branch device.</li><li>iliac anatomy must allow for the delivery of the arch branch device which is loaded within a 20f-24f sheath", "entities": [{"id": 628, "label": "TVariable", "start_offset": 0, "end_offset": 8}, {"id": 629, "label": "TCreVtoV", "start_offset": 10, "end_offset": 15}, {"id": 630, "label": "TValue", "start_offset": 10, "end_offset": 12}, {"id": 631, "label": "TUnit", "start_offset": 15, "end_offset": 17}, {"id": 632, "label": "TValue", "start_offset": 13, "end_offset": 15}, {"id": 633, "label": "TVariable", "start_offset": 17, "end_offset": 37}, {"id": 634, "label": "", "start_offset": -1, "end_offset": -1}, {"id": 635, "label": "TVariable", "start_offset": 42, "end_offset": 65}, {"id": 636, "label": "TValue", "start_offset": 66, "end_offset": 68}, {"id": 637, "label": "TVariable", "start_offset": 87, "end_offset": 105}, {"id": 638, "label": "TVariable", "start_offset": 168, "end_offset": 310}, {"id": 639, "label": "TValue", "start_offset": 311, "end_offset": 312}, {"id": 640, "label": "TVariable", "start_offset": 369, "end_offset": 425}, {"id": 641, "label": "TValue", "start_offset": 489, "end_offset": 490}, {"id": 642, "label": "TValue", "start_offset": 491, "end_offset": 493}, {"id": 643, "label": "TValue", "start_offset": 520, "end_offset": 522}, {"id": 644, "label": "TVariable", "start_offset": 446, "end_offset": 477}, {"id": 645, "label": "TValue", "start_offset": 629, "end_offset": 630}, {"id": 646, "label": "TValue", "start_offset": 631, "end_offset": 633}, {"id": 647, "label": "TValue", "start_offset": 66, "end_offset": 67}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02053909", "pid": "35", "mcid": "43157", "text": "patients undergoing first-time cabg with at least 1 saphenous vein graft, irrespective of concurrent valve surgery", "entities": [{"id": 648, "label": "TVariable", "start_offset": 0, "end_offset": 35}, {"id": 649, "label": "TCreGte", "start_offset": 41, "end_offset": 49}, {"id": 650, "label": "TValue", "start_offset": 50, "end_offset": 51}, {"id": 651, "label": "TUnit", "start_offset": -1, "end_offset": -1}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02000115", "pid": "35", "mcid": "44366", "text": "bulky calcified aortic valve leaflets in close proximity to coronary ostia.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01791543", "pid": "35", "mcid": "47940", "text": "definite protruding left ventricular thrombus on pre-ablation echocardiography when lv ablation is required.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01626079", "pid": "35", "mcid": "49692", "text": "transseptal catheterization and femoral vein access is determined to be feasible by the mitraclip implanting investigator.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01313533", "pid": "35", "mcid": "52086", "text": "first time coronary artery bypass surgery,redo coronary artery bypass surgery and combined valve repair/replacement surgery and coronary artery bypass graft surgery are eligible to participate in study.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT00928356", "pid": "35", "mcid": "53170", "text": "requirement of revascularization of arteries amendable for pci but not accessable by robotic cabg", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT00673842", "pid": "35", "mcid": "53849", "text": "abnormal hrt & twa (core lab interpretation) on holter performed 2 to 60 months after the index mi and the specified time after coronary revascularization", "entities": [{"id": 652, "label": "TVariable", "start_offset": 20, "end_offset": 43}, {"id": 653, "label": "TCreVtoV", "start_offset": 65, "end_offset": 72}, {"id": 654, "label": "TValue", "start_offset": 65, "end_offset": 66}, {"id": 655, "label": "TUnit", "start_offset": 73, "end_offset": 79}, {"id": 656, "label": "TValue", "start_offset": 70, "end_offset": 72}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT00573027", "pid": "35", "mcid": "53969", "text": "obstructive cad 50% luminal diameter stenosis in 1 epicardial coronary artery,", "entities": [{"id": 657, "label": "TVariable", "start_offset": 0, "end_offset": 15}, {"id": 658, "label": "", "start_offset": -1, "end_offset": -1}, {"id": 659, "label": "TValue", "start_offset": 16, "end_offset": 18}, {"id": 660, "label": "TUnit", "start_offset": 18, "end_offset": 19}, {"id": 661, "label": "TValue", "start_offset": 49, "end_offset": 50}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT00488696", "pid": "35", "mcid": "54071", "text": "suitable arterial anatomy for stent-graft", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02316886", "pid": "35", "mcid": "35234", "text": "eligible for percutaneous coronary intervention with absorb bioresorbable vascular scaffold or everolimus eluting stent", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01996436", "pid": "35", "mcid": "44427", "text": "for centers that perform a routine day 7 angiogram post-aneurysm treatment - 50% or more stenosis seen on diagnostic angiogram for asymptomatic patients.", "entities": [{"id": 662, "label": "TVariable", "start_offset": 4, "end_offset": 34}, {"id": 663, "label": "", "start_offset": -1, "end_offset": -1}, {"id": 664, "label": "TValue", "start_offset": 39, "end_offset": 40}, {"id": 665, "label": "TUnit", "start_offset": 35, "end_offset": 38}], "relations": [], "Comments": []}
